Skip to main content

Month: April 2022

Beyond Air® to Participate in Three Upcoming Medical Conferences

GARDEN CITY, N.Y., April 18, 2022 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension and, through its affiliate Beyond Cancer, ultra-high concentration nitric oxide (UNO) for the treatment of solid tumors, today announced that the Company is scheduled to present new data at three upcoming medical conferences. The Pediatric Academic Societies 2022 Meeting (PAS 2022)The Company is scheduled to present new long-term safety data for high concentration inhaled nitric oxide for the treatment of bronchiolitis at the PAS 2022 Meeting, which is scheduled to be held April 21-25 in Denver, Colorado. Details of the...

Continue reading

TELA Bio Appoints D. Taylor Ocasio as General Counsel

MALVERN, Pa., April 18, 2022 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, today announced the hiring of D. Taylor Ocasio as the Company’s new General Counsel (GC). As GC, Mr. Ocasio will lead the Company’s legal and governance efforts. Mr. Ocasio joins TELA with nearly ten years of corporate legal operations and healthcare industry experience. Most recently, Mr. Ocasio served as Deputy General Counsel of Zynerba Pharmaceuticals, a clinical-stage specialty pharmaceutical company, where he helped lead the legal functions and compliance programs. Prior to that, Mr. Ocasio served as...

Continue reading

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

WATERTOWN, Mass., April 18, 2022 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2016 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an aggregate of 56,500 shares of EyePoint Pharmaceuticals common stock to four new employees. The stock options were granted on April 14, 2022. The grants were approved by the Compensation Committee and made as an inducement material to each employee entering into employment with EyePoint Pharmaceuticals in accordance with NASDAQ...

Continue reading

Plug Power Announces the Appointment of Two New Board Members

LATHAM, N.Y., April 18, 2022 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a leading provider of turnkey hydrogen solutions for the global green hydrogen economy, announced today the appointment of two new members to the company’s board of directors: Jean Bua, Chief Financial Officer, executive Vice President and treasurer at NetScout Systems and Kavita Mahtani, Chief Financial Officer, Americas for HSBC, one of the largest banking and financial services organizations in the world. Both appointees will join Plug’s audit committee, with Ms. Bua serving as the committee chair. “We are excited to welcome Jean and Kavita to our board of directors. They bring decades of leadership in key areas, such as M&A strategy implementation, global financial operations, and compliance, that are vital to our future operations and strategy,”...

Continue reading

Natus Medical Incorporated to be acquired by ArchiMed Group for $33.50 per share in cash

Highlights: •        Transaction values Natus Medical, Incorporated at approximately $1.2 billion total equity value•        Pre-announces preliminary financial results for the first quarter ended March 31, 2022 MIDDLETON, Wis., April 18, 2022 (GLOBE NEWSWIRE) — Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions to screen, diagnose, and treat disorders affecting the brain, neural pathways, and eight sensory nervous systems, announced today that it has entered into a definitive agreement to be acquired by an affiliate of ArchiMed (“ArchiMed”), a leading investment firm focused exclusively on the healthcare industry for approximately $1.2 billion. Under the terms of the agreement, Natus shareholders will receive $33.50 in cash for each share of Natus common stock,...

Continue reading

GCM Mining Reports First Quarter 2022 Production; Declares May 16, 2022 Monthly Dividend; Announces First Quarter 2022 Results Webcast

TORONTO, April 18, 2022 (GLOBE NEWSWIRE) — GCM Mining Corp. (“GCM Mining” or the “Company”) (TSX: GCM, OTCQX: TPRFF) announced today that it produced a total of 16,293 ounces of gold in March 2022 at its Segovia Operations bringing the total for the first quarter of 2022 to 49,951 ounces compared with 49,058 ounces from Segovia in the first quarter of 2021. In the first quarter of 2022, the Company also produced 89,782 ounces of silver at Segovia, up from 57,315 ounces of silver in the first quarter last year, together with approximately 252,000 pounds of zinc and 338,000 pounds of lead. Consolidated gold production of 51,486 ounces in the first quarter last year also included 2,428 ounces from Marmato up to February 4, 2021, the date of the loss of control of Aris Gold Corporation. GCM Mining’s trailing 12-months’ total gold production...

Continue reading

Tuna Fish Market to Hit USD 49.70 Billion by 2029 | Strong Demand for Protein Rich Foods to Boost Market Development, Says Fortune Business Insights™

Companies covered in Tuna Fish Market are Bolton Group (Milan, Italy), Century Pacific Foods Inc. (Pasig, Philippines), The Jealsa Rianxeira S.AU. Group Boiro, Spain Grupo Albacore S.A. (Basque Country, Spain), ITOCHU Corporation (Tokyo, Japan), Thai Union Group Inc. (Samut Sakhon, Thailand), Dongwon Enterprises Co. Ltd. (Seoul, South Korea), IBL Ltd. (Port Louis, Mauritius FCF Co. Ltd. (Kaohsiung, Taiwan), Sea Delight (Florida, U.S.), and more players profiled. Pune, India, April 18, 2022 (GLOBE NEWSWIRE) — The global tuna fish market size was USD 40.12 billion in 2021. It is expected to surge from USD 41.06 billion in 2022 to USD 49.70 billion in 2029, exhibiting a CAGR of 2.77% in the forecast period. Robust demand for protein-rich foods and value-added tuna is expected to bolster market development.  Fortune Business Insights™...

Continue reading

FAT Brands Inc. Announces Second Quarter Cash Dividend on Class A Common Stock and Class B Common Stock

Los Angeles, CA, April 18, 2022 (GLOBE NEWSWIRE) — FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT), a leading global franchising company and parent company of iconic brands including Round Table Pizza, Fatburger, Marble Slab Creamery, Johnny Rockets, Twin Peaks, Fazoli’s and 11 other restaurant concepts, announced today that its Board of Directors has declared the Company’s fiscal 2022 second quarter cash dividend of $0.13 per share on each outstanding share of Class A common stock and Class B common stock. The dividend is payable on June 1, 2022 to holders of record of Class A common stock and Class B common stock as of the close of business on May 16, 2022. The declaration and payment of future dividends, as well as the amounts thereof, are subject to the discretion of the Company’s Board of Directors. The amount and...

Continue reading

Solaris Reports In-Pit Resources of 579 Mt at 0.59% CuEq (Ind) & 887 Mt at 0.47% CuEq (Inf), Includes ‘Indicative Starter Pit’ of 180 Mt at 0.82% CuEq (Ind) & 107 Mt at 0.73% CuEq (Inf); Targeting High-Grade Extensions and Major Growth in Cluster

Figure 1 – Warintza Mineral Resource Plan View (1,400m Elevation) Figure 1 – Warintza Mineral Resource Plan View (1,400m Elevation)Figure 2 – Warintza Mineral Resource Long Section Figure 2 – Warintza Mineral Resource Long SectionFigure 3 – Warintza Mineral Resource Cross Section Figure 3 – Warintza Mineral Resource Cross SectionVANCOUVER, British Columbia, April 18, 2022 (GLOBE NEWSWIRE) — Solaris Resources Inc. (TSX: SLS; OTCQB: SLSSF) (“Solaris” or the “Company”) is pleased to report an updated mineral resource estimate (“MRE” or the “Resource”) for the Warintza Central deposit at its Warintza Project (“Warintza” or the “Project”) in southeastern Ecuador. Highlights are listed below, with corresponding images in Figures 1-3 and detailed results in Table 1. HighlightsIn-Pit Indicated mineral resources of 579 million...

Continue reading

Exela Technologies Announces Share Buyback of up to 100 Million Shares of Common Stock at $1.25 per Share Through Exchange Offer for New Class of Preferred Stock

Shareholders can exchange blocks of 20 shares of common stock into a $25 liquidation preference, 6% cumulative dividend, voting, convertible preferred stock $25 liquidation preference represents a 257% premium to the closing share price of $0.35 on April 15, 2022 on a per share of common stock equivalent basis Shares tendered will be retired, reducing share count by approximately 20.6% Holders of Series B Preferred Stock will also be entitled to exchange their shares for an equivalent number of shares of the new class of preferred stock plus a cash payment equal to accrued but unpaid dividends For record holders of stock the expiration time of the offer is 11:59 p.m. on May 16, 2022. Shareholders who hold their stock through a broker or other nominee will likely have an earlier deadline by which they must instruct their broker or nominee...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.